PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Marcos Intaglietta Selected Research
Resuscitation
10/2008
Volume resuscitation from hemorrhagic shock with albumin and hexaPEGylated human serum albumin.
10/2008
Microvascular experimental evidence on the relative significance of restoring oxygen carrying capacity vs. blood viscosity in shock resuscitation.
06/2008
Increased plasma viscosity prolongs microhemodynamic conditions during small volume resuscitation from hemorrhagic shock.
10/2007
Resuscitation from hemorrhagic shock with hydroxyethyl starch and coagulation changes.
04/2007
Is resuscitation from hemorrhagic shock limited by blood oxygen-carrying capacity or blood viscosity?
02/2007
Hemorrhagic shock resuscitation with carbon monoxide saturated blood.
11/2006
Early resuscitation with polymerized bovine hemoglobin reverses acidosis, but not peripheral tissue oxygenation, in a severe hamster shock model.
06/2006
Rapid restoration of microcirculatory blood flow with hyperviscous and hyperoncotic solutions lowers the transfusion trigger in resuscitation from hemorrhagic shock.
07/2005
Early difference in tissue pH and microvascular hemodynamics in hemorrhagic shock resuscitation using polyethylene glycol-albumin- and hydroxyethyl starch-based plasma expanders.
06/2005
Increase plasma viscosity sustains microcirculation after resuscitation from hemorrhagic shock and continuous bleeding.
11/2004
Hyperosmotic-hyperoncotic versus hyperosmotic-hyperviscous: small volume resuscitation in hemorrhagic shock.
10/2004
Resuscitation from hemorrhagic shock with MalPEG-albumin: comparison with MalPEG-hemoglobin.
06/2003
Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters.
09/2002
Systemic and microvascular responses to hemorrhagic shock and resuscitation with Hb vesicles.
Articles by Research Topic
Disease
14
Hemorrhagic Shock
10/2008 - 09/2002
3
Hyperoxia
08/2008 - 10/2003
2
Shock
10/2008 - 11/2006
2
Anemia
03/2008 - 08/2006
2
Malaria
02/2007 - 09/2005
2
Anoxia (Hypoxia)
04/2006 - 04/2005
1
Polycythemia (Erythrocytosis)
02/2007
1
Cerebral Malaria
12/2006
1
Dissociative Disorders (Fugue)
11/2006
1
Acidosis
11/2006
1
Endotoxemia
01/2006
1
Hemorrhage
06/2005
Drug/Important Bio-Agent (IBA)
12
Oxygen
IBA
10/2008 - 10/2003
4
Nitric Oxide (Nitrogen Monoxide)
FDA Link
12/2006 - 09/2005
3
Hemoglobins (Hemoglobin)
IBA
11/2006 - 06/2003
3
Polyethylene Glycols (Polyethylene Glycol)
FDA Link
Generic
01/2006 - 06/2003
2
Serum Albumin
IBA
10/2008 - 01/2008
2
Hetastarch (Pentastarch)
FDA Link
10/2007 - 07/2005
1
HES 130-0.4
IBA
01/2008
1
Carbon Monoxide
IBA
02/2007
1
polymerized bovine hemoglobin
IBA
11/2006
Therapy/Procedure
14
Resuscitation
10/2008 - 09/2002
2
Hemodilution
08/2008 - 01/2008